MHRA approves two new medicines for overactive bladder syndrome and breast cancer
Pierre Fabre Limited receives MHRA marketing authorisation for vibegron, Astra Zeneca UK Limited for Capivasertib
The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday,...
Aquiette 2.5mg Tablets to remain as prescription-only
The Medicines and Healthcare products Regulatory Agency (MHRA) has maintained the prescription-only status of Aquiette 2.5mg Tablets for symptoms of overactive bladder, following a...
MHRA is considering reclassification of Aquiette 2.5mg tablets as pharmacy medicine
The Medicines and Healthcare Products Regulatory Agency (MHRA) is considering the reclassification of Aquiette 2.5mg tablet contains oxybutynin hydrochloride that is used to treat...